These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 12473592

  • 1. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY.
    Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
    [Abstract] [Full Text] [Related]

  • 2. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, Lee HY.
    Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
    [Abstract] [Full Text] [Related]

  • 3. The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis.
    Papadimitrakopoulou VA, Brown EN, Liu DD, El-Naggar AK, Jack Lee J, Hong WK, Lee HY.
    Cancer Lett; 2006 Jul 28; 239(1):136-43. PubMed ID: 16181731
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS.
    Oncol Rep; 2006 Dec 28; 16(6):1205-10. PubMed ID: 17089038
    [Abstract] [Full Text] [Related]

  • 5. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY, Choi BG, Choi JY, Lee SY, Ju SY.
    Lung Cancer; 2006 Nov 28; 54(2):227-34. PubMed ID: 16935391
    [Abstract] [Full Text] [Related]

  • 6. Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients.
    Hastings RH, Laux AM, Casillas A, Xu R, Lukas Z, Ernstrom K, Deftos LJ.
    Clin Cancer Res; 2006 Jan 15; 12(2):499-506. PubMed ID: 16428492
    [Abstract] [Full Text] [Related]

  • 7. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.
    Soria JC, Moon C, Kemp BL, Liu DD, Feng L, Tang X, Chang YS, Mao L, Khuri FR.
    Clin Cancer Res; 2003 May 15; 9(5):1785-91. PubMed ID: 12738735
    [Abstract] [Full Text] [Related]

  • 8. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
    Kim YH, Sumiyoshi S, Hashimoto S, Masago K, Togashi Y, Sakamori Y, Okuda C, Mio T, Mishima M.
    Clin Lung Cancer; 2012 Sep 15; 13(5):385-90. PubMed ID: 22285568
    [Abstract] [Full Text] [Related]

  • 9. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May 15; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 10. Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer.
    Chang MH, Lee J, Han J, Park YH, Ahn JS, Park K, Ahn MJ.
    APMIS; 2009 Dec 15; 117(12):861-9. PubMed ID: 20078550
    [Abstract] [Full Text] [Related]

  • 11. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T.
    Cancer; 2007 Jun 15; 109(12):2506-14. PubMed ID: 17487846
    [Abstract] [Full Text] [Related]

  • 12. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
    Ishikawa S, Nakagawa T, Miyahara R, Kawano Y, Takenaka K, Yanagihara K, Otake Y, Katakura H, Wada H, Tanaka F.
    Clin Cancer Res; 2005 Feb 01; 11(3):1198-202. PubMed ID: 15709189
    [Abstract] [Full Text] [Related]

  • 13. Maspin expression and its clinical significance in non-small cell lung cancer.
    Nakagawa M, Katakura H, Adachi M, Takenaka K, Yanagihara K, Otake Y, Wada H, Tanaka F.
    Ann Surg Oncol; 2006 Nov 01; 13(11):1517-23. PubMed ID: 17009165
    [Abstract] [Full Text] [Related]

  • 14. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T, Nakagawa K, Nakamura H, Takada Y, Matsui K, Kawahara K.
    Oncol Rep; 2005 Jun 01; 13(6):1075-80. PubMed ID: 15870924
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 01; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 16. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
    Caputi M, Groeger AM, Esposito V, De Luca A, Masciullo V, Mancini A, Baldi F, Wolner E, Giordano A.
    Clin Cancer Res; 2002 Dec 01; 8(12):3850-6. PubMed ID: 12473599
    [Abstract] [Full Text] [Related]

  • 17. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 18. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E, Moro D, Gazzeri S, Brambilla C.
    J Pathol; 1999 Aug 15; 188(4):351-60. PubMed ID: 10440744
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J, Dmitrovsky E.
    Clin Cancer Res; 1997 Apr 15; 3(4):515-22. PubMed ID: 9815714
    [Abstract] [Full Text] [Related]

  • 20. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    Histopathology; 2009 Jun 15; 54(7):804-13. PubMed ID: 19635099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.